Clinical trial

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome…

NCT00172185 · Shire, Industry · Completed

Key facts

NCT number NCT00172185
Title Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
Official title A Study of the Safety and Efficacy of Teduglutide in Subjects With Parenteral Nutrition-Dependent Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
Lead sponsor Shire, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Short Bowel Syndrome
Intervention type Drug
Interventions teduglutide 0.05 mg/kg/d, teduglutide 0.10 mg/kg/d
Enrollment 65
Start date Jan 10, 2005
Primary completion Jan 24, 2008
Completion Jan 24, 2008
First posted Sep 15, 2005
Last update posted Jun 2, 2021
Countries Belgium, Canada, Denmark, France, Netherlands, Poland, United Kingdom, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies